Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists

Gregory Lip, LH Rasmussen, SB Olsson, EC Jensen, AL Persson, U Eriksson, KF Wåhlander

Research output: Contribution to journal › Article

89 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists'. Together they form a unique fingerprint.

Medicine & Life Sciences